Definiens AG

Definiens is a leading Health Image Intelligence™ company that develops software solutions for biomedical image analysis, data mining and clinical decision support. The companys software analyzes images from cell-based assays, whole tissue slides and full body scans and allows users to correlate this information with data derived from other sources, supporting better decisions in research, diagnostics and therapy. By automating analysis workflows and generating new knowledge, Definiens provides pharmaceutical and biotechnology companies, research institutions, clinical service organizations and medical professionals with deeper insights, faster results and better decision support. Harnessing the power of image intelligence, Definiens supports personalized medicine and aims to significantly improve the quality of patients lives.

Definiens software frees clinicians and scientists from poring over images, enabling them to focus on the critical work of investigation and interpretation:

- Clinicians can provide more accurate and informed patient care based on highly detailed and rich analysis of tissue slides or full body scans.
- Scientists can run any size of study and correlate the image data with other types of information, such as experimental conditions or patient outcomes. This allows them to understand the mechanisms of disease, validate targets, identify relevant biomarkers and open new avenues of research.
As the amount of image data grows exponentially, automation of image and data analysis is the only way to reduce the information bottleneck. Definiens revolutionary technology provides unprecedented accuracy in identifying and quantifying biological attributes within images and turning them into knowledge.

Definiens is headquartered in Munich, Germany, and has offices throughout the United States.